Open access
Sep 2026
HIF-1α-ASS1 axis drives reprogramming of arginine metabolism controls hepatic stellate cell activation in hepatic fibrosis.
ABRL8301 acts as a pharmacologic inducer of ASS1 and arginine biosynthesis, inhibiting EMT and fibrotic progression while enhancing anticancer therapy and support ABRL8301 as a promising antifibrotic and tumor-sensitizing agent in hepatic fibrosis.
Seungeun Lee, Yeonhwa Song, Sanghwa Kim et al.
· Phytomedicine · 0 citations